Wall Chart Featuring  Skin-Related Toxicities of Targeted Therapies

Clinicians focused on CLL, follicular lymphoma, and MCL gathered during a Frontline Forum to discuss the use of BTKi in each respective disease state.

T-DXd Sequencing and Treatment Options in the Tumor-Agnostic Setting

ONCOLOGY Staff

November 15th 2024

Article

HER-directed treatment approaches in the tumor-agnostic field were the highlight of the discussion for a panel of experts who convened at WCLC 2024.

Related Content

Multiple Myeloma Experts Face Off on Sequencing Therapy Options

ONCOLOGY Staff

November 21st 2024

Article

Experts in multiple myeloma gathered to debate current treatment options in the space during a recent Face Off.

Stem Cell Transplant Approaches for Patients With Blood Cancers

David T. Scadden, MD

March 13th 2019

Podcast

Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.

Addressing Gaps in Education for Non–Clear Cell RCC

ONCOLOGY Staff

November 19th 2024

Article

A panel discussed on RCC and the differentiation in the identification and treatment of clear and non-clear cell RCC.

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Geoffrey Y. Ku, MD

March 13th 2019

Podcast

Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.

BTK Inhibitor Treatment Options Across the Lymphoma Landscape

ONCOLOGY Staff

November 17th 2024

Article

Clinicians focused on CLL, follicular lymphoma, and MCL gathered during a Frontline Forum to discuss the use of BTKi in each respective disease state.

T-DXd Sequencing and Treatment Options in the Tumor-Agnostic Setting

ONCOLOGY Staff

November 15th 2024

Article

HER-directed treatment approaches in the tumor-agnostic field were the highlight of the discussion for a panel of experts who convened at WCLC 2024.